← Back to headlines
Travere Therapeutics Positioned for Long-Term Growth in Rare Disease Market
Travere Therapeutics, Inc. (TVTX) is seen as well-positioned for long-term growth within the rare disease market.
18 Feb, 06:10 — 18 Feb, 06:10
Travere Therapeutics, Inc. (TVTX) is seen as well-positioned for long-term growth within the rare disease market.
18 Feb, 06:10 — 18 Feb, 06:10
